View all newsletters
Receive our newsletter - data, insights and analysis delivered to you
  1. Deals Analysis
February 18, 2022

Europe’s medical devices industry saw a rise of 55% in cross border deal activity during January 2022

By Nikitha Ladda

Europe’s medical devices industry saw a rise of 55% in cross border deal activity during January 2022, when compared with the last 12-month average, led by Ardian Holding ’s $1.26bn private equity deal for 70% stake in Biofarma, according to GlobalData’s deals database.

  • Embed this chart

    Embed this chart into your website

    Copy and paste the image source into your website to display the chart.

A total of 31 medical devices industry cross border deals worth $1.7bn were announced for the region in January 2022, against the 12-month average of 20 deals.

Of all the deal types, M&A saw most activity in January 2022 with 14 transactions, representing a 45.2% share for the region.

In second place was venture financing with 13 deals, followed by private equity deals with four transactions, respectively capturing a 41.9% and 12.9% share of the overall cross border deal activity for the month.

In terms of value of cross border deals, private equity was the leading category in Europe’s medical devices industry with $1.28bn, while venture financing and M&A deals totalled $379.18m and $7.12m, respectively.

Europe medical devices industry cross border deals in January 2022: Top deals

The top five medical devices cross border deals accounted for 91.4% of the overall value during January 2022.

The combined value of the top five medical devices cross border deals stood at $1.52bn, against the overall value of $1.7bn recorded for the month.

The top five medical devices industry cross border deals of January 2022 tracked by GlobalData were:

1) Ardian Holding $1.26bn private equity deal for 70% stake in Biofarma

2) The $90m venture financing of DistalMotion by 415 Capital Management and Revival Healthcare

3) ARCH Venture Partners,ARTIS Ventures,Axon Ventures,Casdin Capital,Oxford Science Enterprises,Section 32 and Vertical Venture Partners $75m venture financing deal with Oni

4) The $55m venture financing of InnovHeart by Genextra,Grand Pharmaceutical Group,Indaco Venture Partners SGR and Panakes Partners

5) Genesis MedTech International and Sofinnova Partners $44.59m venture financing deal with Safeheal

Related Companies

Verdict deals analysis methodology

This analysis considers only announced and completed cross border deals from the GlobalData financial deals database and excludes all terminated and rumoured deals. Country and industry are defined according to the headquarters and dominant industry of the target firm. The term ‘acquisition’ refers to both completed deals and those in the bidding stage.

GlobalData tracks real-time data concerning all merger and acquisition, private equity/venture capital and asset transaction activity around the world from thousands of company websites and other reliable sources.

More in-depth reports and analysis on all reported deals are available for subscribers to GlobalData’s deals database.

Topics in this article: ,
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Medical Device Network